Cargando…
Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients for the Treatment of Severe Aortic Stenosis
Recently, two randomized trials, the PARTNER 3 and the Evolut Low Risk Trial, independently demonstrated that transcatheter aortic valve replacement (TAVR) is non-inferior to surgical aortic valve replacement (SAVR) for the treatment of severe aortic stenosis in patients at low surgical risk, paving...
Autores principales: | Polimeni, Alberto, Sorrentino, Sabato, De Rosa, Salvatore, Spaccarotella, Carmen, Mongiardo, Annalisa, Sabatino, Jolanda, Indolfi, Ciro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074202/ https://www.ncbi.nlm.nih.gov/pubmed/32041189 http://dx.doi.org/10.3390/jcm9020439 |
Ejemplares similares
-
Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
por: Sabatino, Jolanda, et al.
Publicado: (2021) -
Non-Invasive Myocardial Work in Patients with Severe Aortic Stenosis
por: De Rosa, Salvatore, et al.
Publicado: (2022) -
Description and Validation of TAVIApp: A Novel Mobile Application for Support of Physicians in the Management of Aortic Stenosis—Management of Aortic Stenosis with TAVIApp
por: Indolfi, Ciro, et al.
Publicado: (2017) -
The five-year outcome of the transcatheter aortic valve replacement in the partner 2A study in patients with intermediate surgical risk—what is clear and what it is unclear
por: Spaccarotella, Carmen, et al.
Publicado: (2020) -
Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients
por: Polimeni, Alberto, et al.
Publicado: (2021)